# Postoperative Bleeding Prevention in Massive Bone Tumour Resection

> **NCT02153593** · PHASE3 · TERMINATED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 56 (actual)

## Conditions studied

- Blood Loss
- Bone Tumour

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Fibrin glue
- **PROCEDURE:** Electrocauterization

## Key facts

- **NCT ID:** NCT02153593
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-05
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Difficulty in recruitment
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153593, "Postoperative Bleeding Prevention in Massive Bone Tumour Resection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02153593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*